Margit L W Juhász1, Melissa K Levin, Ellen S Marmur. 1. *Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York; †Marmur Medical, New York, New York; ‡Department of Dermatology, The Mount Sinai Hospital, New York, New York.
Abstract
BACKGROUND: Hyaluronidase is an enzyme capable of dissolution of hyaluronic acid (HA). There is a lack of evidence-based research defining time- and concentration-dependent reversal of HA filler using hyaluronidase. OBJECTIVE: To explore the efficacy of different concentrations of hyaluronidase in digesting commercially available HA-based reversible fillers-Belotero Balance (BEL), Juvederm Ultra XC (JUVXC), Juvederm Ultra Plus (JUVX+), Juvederm Voluma XC (JUVV), Restylane-L (RESL), Restylane Silk (RESS), and Perlane/Restylane Lyft (RESLYFT). MATERIALS AND METHODS: This was a blinded randomized study involving 15 participants. Participants received HA filler injection into their back, followed by no secondary injection, or injection with normal saline, 20 or 40 units of hyaluronidase. Using a 5-point palpation scale, the degradation of HA filler was monitored over 14 days. RESULTS: In the authors' study, there is a significant decrease in HA filler degradation using 20 and 40 units of hyaluronidase compared with no secondary injection or normal saline. There is no significant difference in HA filler dissolution when comparing 20 to 40 units of hyaluronidase. CONCLUSION: Lower concentrations of hyaluronidase may be just as effective as higher concentrations to degrade HA filler in situations where the reversal of cutaneous augmentation with HA filler arises.
RCT Entities:
BACKGROUND: Hyaluronidase is an enzyme capable of dissolution of hyaluronic acid (HA). There is a lack of evidence-based research defining time- and concentration-dependent reversal of HA filler using hyaluronidase. OBJECTIVE: To explore the efficacy of different concentrations of hyaluronidase in digesting commercially available HA-based reversible fillers-Belotero Balance (BEL), Juvederm Ultra XC (JUVXC), Juvederm Ultra Plus (JUVX+), Juvederm Voluma XC (JUVV), Restylane-L (RESL), Restylane Silk (RESS), and Perlane/Restylane Lyft (RESLYFT). MATERIALS AND METHODS: This was a blinded randomized study involving 15 participants. Participants received HA filler injection into their back, followed by no secondary injection, or injection with normal saline, 20 or 40 units of hyaluronidase. Using a 5-point palpation scale, the degradation of HA filler was monitored over 14 days. RESULTS: In the authors' study, there is a significant decrease in HA filler degradation using 20 and 40 units of hyaluronidase compared with no secondary injection or normal saline. There is no significant difference in HA filler dissolution when comparing 20 to 40 units of hyaluronidase. CONCLUSION: Lower concentrations of hyaluronidase may be just as effective as higher concentrations to degrade HA filler in situations where the reversal of cutaneous augmentation with HA filler arises.
Authors: Gregor Cornelius Weber; Bettina Alexandra Buhren; Holger Schrumpf; Johannes Wohlrab; Peter Arne Gerber Journal: Adv Exp Med Biol Date: 2019 Impact factor: 2.622
Authors: Bettina Alexandra Buhren; Holger Schrumpf; Edwin Bölke; Kai Kammers; Peter Arne Gerber Journal: Eur J Med Res Date: 2018-08-20 Impact factor: 2.175
Authors: Seong Sung Kwak; Kwang Ho Yoon; Jin Hee Kwon; Won-Ho Kang; Chang-Hoon Rhee; Gi-Hyeok Yang; Deu John M Cruz; Woo-Chan Son Journal: Clin Cosmet Investig Dermatol Date: 2021-03-08
Authors: Wim H De Jong; Danyel Jennen; Peter H J Keizers; Hennie M Hodemaekers; Jolanda P Vermeulen; Frank Bakker; Paul Schwillens; Marcel van Herwijnen; Marlon Jetten; Jos C S Kleinjans; Robert E Geertsma; Rob J Vandebriel Journal: Int J Mol Sci Date: 2022-06-30 Impact factor: 6.208